753 (Temozolomide 100 mg)
Pill with imprint 753 is Pink & White, Capsule-shape and has been identified as Temozolomide 100 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..
Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 753
Temozolomide
- Imprint
- 753
- Strength
- 100 mg
- Color
- Pink & White
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0753
- Inactive Ingredients
-
lactose anhydrous, sodium starch glycolate type B potato, tartaric acid, stearic acid, butyl alcohol, alcohol, ferrosoferric oxide, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, ammonia, water, gelatin, titanium dioxide, sodium lauryl sulfate, FD&C Red No. 3, D&C Yellow No. 10, silicon dioxide
Note: Inactive ingredients may vary.
Related Images for "753"
More about temozolomide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 9 Reviews
- Drug class: alkylating agents
Consumer resources
- Temozolomide
- Temozolomide Capsules
- Temozolomide Injection
- Temozolomide (Advanced Reading)
- Temozolomide Intravenous (Advanced Reading)
Other brands: Temodar
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
